AI MARKET SCANNING

Aytu BioPharma, Inc.

📅 Next Catalyst: Nov 16, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP +2.10%
MAX GAP RECORD +43.70%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $AYTU
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 16, 2026 Earnings Release 2026-11-16 (UNDETERMINED) 🔮 UPCOMING 🔒
Sep 22, 2026 Earnings Release 2026-09-22 (AFTER CLOSE (16:00))
+4.93%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+3.56%
Feb 03, 2026 Earnings Release 2026-02-03 (AFTER CLOSE)
-4.58%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+2.91%
Sep 23, 2025 Earnings Release 2025-09-23 (AFTER CLOSE)
-12.35%
May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE)
+43.70%
Feb 12, 2025 Earnings Release 2025-02-12 (AFTER CLOSE)
+5.04%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.8%
Bullish Gaps (9)
Bearish Gaps (6)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $AYTU

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗